Sprinklr Announces First Quarter Fiscal 2025 Results and Appoints Trac Pham as Co-Chief Executive Officer

Go back to Sprinklr Announces First Quarter Fiscal 2025 Results and Appoints Trac Pham as Co-Chief Executive Officer
Cardium Therapeutics, Inc. (NYSE: CXM) Delayed: 5.03 +0.08 (1.62%)
Previous Close $4.95    52 Week High $1.44 
Open $5.05    52 Week Low $0.06 
Day High $5.09    P/E N/A 
Day Low $4.94    EPS $-1.24 
Volume 1,117,607